Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huare Dingxin Technology is a specialized medical technology company headquartered in Beijing, China, dedicated to the field of oncological hyperthermia. The company develops and manufactures high-end medical equipment, most notably the Endogenous Thermal Field Tumor Hyperthermia System, which is designed to treat malignant tumors through controlled heat application. This technology is primarily used as an adjuvant therapy to enhance the effectiveness of traditional treatments like chemotherapy and radiotherapy. Huare Dingxin's systems are utilized in numerous clinical institutions across China, focusing on non-invasive solutions for deep-seated tumors in the abdomen and pelvis. The company maintains a strong focus on research and development to advance thermal medicine and improve patient outcomes in cancer care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Huare Dingxin Technology.